This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trimarco, B. Articles by Condorelli, M. Search for Related Content PubMed PubMed Citation Articles by Trimarco, B. Articles by Condorelli, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB EPINEPHRINE SODIUM CHLORIDE Medline Plus Health Information High Blood Pressure

Hypertension, Vol 5, 584-590, Copyright © 1983 by American Heart Association

ARTICLES

Studies of the mechanisms underlying impairment of beta-adrenoceptor- mediated effects in human hypertension

B Trimarco, M Volpe, B Ricciardelli, GB Picotti, MD Galva, R Petracca and M Condorelli

To investigate the impairment of beta-adrenoceptor responsiveness in human hypertension, we evaluated the effect of an oral salt load (400 mEq/day of NaCl for 7 days) on plasma catecholamine concentrations and beta-adrenoceptor-mediated effects in 11 young patients with mild essential hypertension. Responses of heart rate and plasma cAMP to isoproterenol administration were used as indices of beta-adrenoceptor responsiveness. Salt loading induced a significant reduction in the dose of isoproterenol required to raise the heart rate by 25 bpm (CD25) (from 7.6 +/- 1.5 to 5.3 +/- 0.9 micrograms, p less than 0.05) and an increase in the slopes of the regression lines for heart rate changes and isoproterenol doses (delta HR/IS) (from 3.3 +/- 0.6 to 4.7 +/- 0.7, p less than 0.05) and for plasma cyclic AMP (cAMP) level changes and isoproterenol doses (delta cAMP/IS) (from 0.3 +/- 0.06 to 1.4 +/- 0.3, p less than 0.05). After salt loading there was a significant reduction in plasma catecholamine concentrations with a significant relationship between changes in upright plasma epinephrine levels and changes in CD25 (r = 0.904, p less than 0.01) and in the slopes for delta HR/IS (r = 0.983, p less than 0.001) and delta cAMP/IS (r = 0.922, p less than 0.001). These results support the hypothesis that the impairment of beta-adrenoceptor sensitivity observed in human hypertension is associated with a beta-adrenoceptor overstimulation due to chronically elevated adrenergic tone.

This article has been cited by other articles:

				Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, K. Sugimoto, Y. Fu, M. Motone, K. Yamamoto, A. Matsuo, et al. Hypoadiponectinemia Is an Independent Risk Factor for Hypertension Hypertension, June 1, 2004; 43(6): 1318 - 1323. [Abstract] [Full Text] [PDF]

				S. Julius, M. Valentini, and P. Palatini Overweight and Hypertension : A 2-Way Street? Hypertension, March 1, 2000; 35(3): 807 - 813. [Abstract] [Full Text] [PDF]

				P. Palatini, O. Vriz, S. Nesbitt, J. Amerena, S. Majahalme, M. Valentini, and S. Julius Parental Hyperdynamic Circulation Predicts Insulin Resistance in Offspring : The Tecumseh Offspring Study Hypertension, March 1, 1999; 33(3): 769 - 774. [Abstract] [Full Text] [PDF]

				A. Elhendy, R. T. van Domburg, J. R. T. C. Roelandt, M. L. Geleijnse, M. M. Ibrahim, and P. M. Fioretti Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients Hypertension, June 1, 1997; 29(6): 1232 - 1239. [Abstract] [Full Text]

				A. Sherwood, A. L. Hinderliter, and K. C. Light Physiological Determinants of Hyperreactivity to Stress in Borderline Hypertension Hypertension, March 1, 1995; 25(3): 384 - 390. [Abstract] [Full Text]